Lidocain Egis

Lidocaine, the active ingredient in Lidocain Egis, is a local anesthetic presented as a topical preparation for cutaneous use. It provides surface anesthesia for minor skin procedures and relieves localized pain. It is commonly applied in a thin layer to the intended area and is absorbed locally, producing rapid onset of numbness without systemic effects when used as directed.

GNH USA supplies Lidocain Egis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows Good Distribution Practice and holds the necessary authorizations to export pharmaceutical products across the European Union and other regulated markets.

Lidocaine is employed as a topical local anesthetic for conditions affecting the skin and superficial tissues.

Minor skin surgery: provides localized numbness to reduce pain during excisions, suturing or biopsies. Dermatologic procedures: numbs the area for laser therapy, cryotherapy or cosmetic treatments. Minor burns and abrasions: alleviates discomfort and itching associated with superficial thermal injuries.

Topical lidocaine may cause a range of local and systemic reactions, varying from mild irritation to rare serious events.

Common Side Effects: - Skin irritation: redness or mild rash at the application site - Pruritus: itching around the treated area - Burning sensation: transient warmth or tingling - Dryness: mild dryness of the skin

Serious or Rare Side Effects: - Systemic toxicity: dizziness, seizures, or cardiac arrhythmia if absorbed in excess - Allergic reaction: hives, swelling, or anaphylaxis - Methemoglobinemia: bluish discoloration of skin and mucous membranes - Severe skin reaction: Stevens‑Johnson syndrome or toxic epidermal necrolysis

When using Lidocain Egis, consider the following safety measures to minimize risks. - Allergy assessment: avoid if the patient has known hypersensitivity to lidocaine or other amide anesthetics - Application area: limit use to intact, non‑mucosal skin and avoid large surface areas - Dosage limit: do not exceed the recommended amount or frequency indicated by the prescriber - Concurrent anesthetics: exercise caution when other local anesthetics are used simultaneously - Medical conditions: use with care in patients with cardiac conduction disorders or severe liver disease - Store at room temperature: keep in the original container, protect from moisture and direct sunlight

Lidocaine can interact with other medicines, affecting its safety or effectiveness.

Major Interactions (Avoid): - Other amide local anesthetics: additive risk of systemic toxicity - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may enhance cardiac conduction effects - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can increase lidocaine plasma concentrations

Moderate Interactions (Monitor Closely): - Beta‑blockers or calcium channel blockers: may potentiate cardiovascular depression - Diuretics such as furosemide: may alter protein binding and increase free lidocaine - General anesthetics (e.g., propofol, inhalational agents): may augment central nervous system depression